Ferozsons Laboratories Ltd. Report issue

For profit Phase 4
Founded: Lahore Pakistan (1954)
Status: No NME R&D (1954)

Organization Overview

First Clinical Trial
2006
NCT00369694
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Ferozsons Laboratories Ltd.

Active Ingredients

Drugs in Phase 4 Trials (3)

atenolol (tenormin) (1 trial)

nicorandil (1 trial)

terlipressin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Angina, Stable (Phase 4)

Esophageal and Gastric Varices (Phase 4)

Hemorrhage (Phase 4)

Hypertension (Phase 4)

Hypertension, Portal (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3